Sintx Technologies (NASDAQ:SINT – Get Free Report) is expected to be announcing its Q2 2026 results before the market opens on Tuesday, August 11th. Analysts expect the company to announce earnings of ($0.73) per share and revenue of $0.46 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 4:30 PM ET.
Sintx Technologies (NASDAQ:SINT – Get Free Report) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by ($0.04). Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%.The company had revenue of $0.38 million during the quarter, compared to analyst estimates of $0.30 million. On average, analysts expect Sintx Technologies to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Sintx Technologies Price Performance
SINT stock opened at $1.66 on Monday. The business’s 50-day simple moving average is $1.84 and its 200 day simple moving average is $2.41. Sintx Technologies has a twelve month low of $1.40 and a twelve month high of $6.78. The company has a market cap of $7.17 million, a PE ratio of -0.33 and a beta of 0.62.
Institutional Investors Weigh In On Sintx Technologies
Wall Street Analyst Weigh In
SINT has been the topic of a number of recent research reports. HC Wainwright reiterated a “buy” rating and set a $10.00 price target on shares of Sintx Technologies in a research note on Wednesday, May 20th. Maxim Group restated a “buy” rating and set a $6.00 price target on shares of Sintx Technologies in a research report on Thursday, June 4th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $9.33.
View Our Latest Analysis on Sintx Technologies
About Sintx Technologies
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.
Read More
- Five stocks we like better than Sintx Technologies
- Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
- Can DICK’S Turn Foot Locker Into a Winner?
- Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue
- Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
